Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities.

Warkentin TE, Sheppard JA, Chu FV, Kapoor A, Crowther MA, Gangji A.

Blood. 2015 Jan 1;125(1):195-8. doi: 10.1182/blood-2014-07-590844. Epub 2014 Nov 18.

PMID:
25406354
2.

HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux-induced HIT.

Warkentin TE, Sheppard JA, Manheim JC.

Thromb Haemost. 2014 Dec;112(6):1319-22. doi: 10.1160/TH14-08-0711. Epub 2014 Oct 16. No abstract available.

PMID:
25319237
3.

Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite "Therapeutic" Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding.

Smythe MA, Forsyth LL, Warkentin TE, Smith MD, Sheppard JA, Shannon F.

J Cardiothorac Vasc Anesth. 2015 Oct;29(5):1319-21. doi: 10.1053/j.jvca.2014.04.029. Epub 2014 Aug 29. No abstract available.

PMID:
25169901
4.

Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.

Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansdell D, McIntyre L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Khwaja K, Sheppard JA, Warkentin TE; PROTECT collaborators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group.

J Crit Care. 2014 Jun;29(3):470.e7-15. doi: 10.1016/j.jcrc.2014.02.004. Epub 2014 Feb 14.

PMID:
24726205
5.

Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin.

Warkentin TE, Sheppard JA.

Blood. 2014 Apr 17;123(16):2485-93. doi: 10.1182/blood-2013-10-533083. Epub 2014 Feb 10.

PMID:
24516044
6.

The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome.

Warkentin TE, Chakraborty AK, Sheppard JA, Griffin DK.

Thromb Haemost. 2012 Aug;108(2):394-6. doi: 10.1160/TH12-03-0201. Epub 2012 May 25. No abstract available.

PMID:
22627967
7.

The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by "true" heparin-induced thrombocytopenia.

Warkentin TE, Moore JC, Vogel S, Sheppard JA, Warkentin NI, Eikelboom JW.

Thromb Haemost. 2012 May;107(5):998-1000. doi: 10.1160/TH11-12-0839. Epub 2012 Feb 28. No abstract available.

PMID:
22371139
8.

Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients.

Kawano H, Yamamoto H, Miyata S, Izumi M, Hirano T, Toratani N, Kakutani I, Sheppard JA, Warkentin TE, Kada A, Sato S, Okamoto S, Nagatsuka K, Naritomi H, Toyoda K, Uchino M, Minematsu K.

Br J Haematol. 2011 Aug;154(3):378-86. doi: 10.1111/j.1365-2141.2011.08775.x. Epub 2011 Jun 14.

9.

Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.

Selleng K, Warkentin TE, Sheppard JA, Greinacher A.

Transfusion. 2009 Sep;49(9):1812-8. doi: 10.1111/j.1537-2995.2009.02205.x. Epub 2009 May 20.

PMID:
19497062
10.

Studies of the immune response in heparin-induced thrombocytopenia.

Warkentin TE, Sheppard JA, Moore JC, Cook RJ, Kelton JG.

Blood. 2009 May 14;113(20):4963-9. doi: 10.1182/blood-2008-10-186064. Epub 2009 Jan 14.

PMID:
19144981
11.

The temporal profile of the anti-PF4/heparin immune response.

Greinacher A, Kohlmann T, Strobel U, Sheppard JA, Warkentin TE.

Blood. 2009 May 14;113(20):4970-6. doi: 10.1182/blood-2008-08-173062. Epub 2008 Dec 23.

PMID:
19109231
12.

Serologic detection of Angiostrongylus vasorum infection in dogs.

Verzberger-Epshtein I, Markham RJ, Sheppard JA, Stryhn H, Whitney H, Conboy GA.

Vet Parasitol. 2008 Jan 25;151(1):53-60. Epub 2007 Nov 5.

PMID:
17981397
13.

Testing for heparin-induced thrombocytopenia antibodies.

Warkentin TE, Sheppard JA.

Transfus Med Rev. 2006 Oct;20(4):259-72. Review.

PMID:
17008164
14.

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia.

Warkentin TE, Sheppard JA, Sigouin CS, Kohlmann T, Eichler P, Greinacher A.

Blood. 2006 Nov 1;108(9):2937-41. Epub 2006 Jul 20.

PMID:
16857993
15.

Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.

Warkentin TE, Greinacher A, Craven S, Dewar L, Sheppard JA, Ofosu FA.

Thromb Haemost. 2005 Nov;94(5):958-64.

PMID:
16363236
16.

Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?

Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG.

J Lab Clin Med. 2005 Dec;146(6):341-6.

PMID:
16310517
17.

Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.

Warkentin TE, Cook RJ, Marder VJ, Sheppard JA, Moore JC, Eriksson BI, Greinacher A, Kelton JG.

Blood. 2005 Dec 1;106(12):3791-6. Epub 2005 Aug 18.

18.

Impact of the patient population on the risk for heparin-induced thrombocytopenia.

Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG.

Blood. 2000 Sep 1;96(5):1703-8.

PMID:
10961867
22.

Production of monoclonal antibodies specific for antigens derived from tissue of chinook salmon (Oncorhynchus tshawytscha) affected with plasmacytoid leukemia.

Newbound GC, Markham RJ, Speare DJ, Saksida SM, Despr├ęs BM, Horney BS, Kibenge FS, Sheppard JA, Wright GM, Kent ML.

Am J Vet Res. 1993 Sep;54(9):1426-31.

PMID:
8239128
23.

Intracranial tumors found at autopsy in mental patients.

PATTON RB, SHEPPARD JA.

Am J Psychiatry. 1956 Oct;113(4):319-24. No abstract available.

PMID:
13362625

Supplemental Content

Loading ...
Support Center